News from cynosure, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 17, 2021, 04:00 ET Cynosure Announces Grand Opening of State-of-the-Art Experience Centre in London

Cynosure announced today the grand opening of its new Cynosure Experience Centre in London. Complete with new research and training facilities,...

Apr 30, 2021, 08:30 ET Cynosure to Acquire MyEllevate, Innovative Minimally Invasive Facial Rejuvenation Treatment

Cynosure announced today at The Aesthetic Society's "The Aesthetic Meeting 2021" that it has entered into an agreement to acquire the MyEllevate®...

Apr 26, 2021, 09:00 ET Cynosure Expands Best-In-Class Potenza™ RF Microneedling System with New Fusion Tip for Enhanced Topical Penetration

Cynosure announced today the U.S. launch of its one-of-a-kind Fusion Tip, the newest addition to its best-in-class Potenza™ radiofrequency (RF)...

Feb 01, 2021, 09:00 ET Kellie Teal-Guess Joins Cynosure as Chief Human Resources Officer

Cynosure announced today that Kellie Teal-Guess will join its Executive Leadership Team as the new Chief Human Resources Officer, effective...

Jan 11, 2021, 09:00 ET Medical Device Industry Executive Mark Didio Joins Cynosure

Cynosure announced today that Mark Didio will join Cynosure's Executive Leadership Team as the company's new global General Manager of Surgical. An...

Jan 04, 2021, 10:00 ET Cynosure Nabs Marketing Expert Katie Cheng As New Chief Marketing Officer

Cynosure announced today that Katie Cheng will join Cynosure as its new Chief Marketing Officer. With more than 25 years of diverse experience in...

Oct 19, 2020, 09:00 ET Cynosure Names MedTech Leader Sujat Sukthankar Executive Vice President of Research & Product Development

Cynosure announced the appointment of Sujat Sukthankar, former VP of Platform Engineering at Becton Dickinson and Vice President of R&D at Boston...

Oct 05, 2020, 09:00 ET Cynosure Launches FlexSure™ Device, World's First Wrappable Radiofrequency (RF) Applicator, for Hands-Free Treatment on All Patients and All Skin Types

Cynosure announced today the U.S. and Canadian launch of FlexSureTM, the latest addition to its best-in-class TempSure® 300-watt platform and the...

Sep 16, 2020, 13:00 ET Cynosure Names Medical Aesthetics Pioneer, Rafael Sierra Ph.D., R&D Advisor

Cynosure announced today its former Chief Technology Officer, Rafael Sierra Ph.D., will once again join the Cynosure team as our R&D Advisor. A true...

Sep 10, 2020, 13:00 ET Cynosure Taps Consumer Products Veteran Anne Gates for Its Board of Directors

Cynosure announced today that Anne Gates, former President at MGA Entertainment, the world's largest private toy company, and Executive Vice...

Feb 07, 2017, 07:00 ET Cynosure Achieves Record Quarterly Revenue of $122.1 Million in the Fourth Quarter of 2016, Up 19 Percent Year-over-Year

Fourth-Quarter 2016 Highlights: North American product revenue up 24 percent to $69.5 million International product revenue up 12 percent to $33.2...

Jan 06, 2017, 12:15 ET Cynosure to Host Fourth-Quarter 2016 Financial Results Conference Call on February 7

Cynosure, Inc. (Nasdaq: CYNO), which designs, manufactures and markets medical devices for aesthetic procedures and precision surgical applications...

Nov 29, 2016, 08:30 ET Cynosure Receives CFDA Clearance to Market the Icon™ Aesthetic System in China

Cynosure, Inc. (NASDAQ: CYNO) today announced that it has received clearance from the China Food and Drug Administration (CFDA) to market the Icon™...

Nov 10, 2016, 08:30 ET Cynosure to Participate in Stifel 2016 Healthcare Conference

Cynosure, Inc. (NASDAQ: CYNO) today announced that President and Chief Executive Officer Michael Davin and Steve Webber, the Company's Chief...

Oct 25, 2016, 08:00 ET Cynosure Announces Record Third-Quarter Revenues; Revenues Increase 36 Percent from Prior Year to $106.4 Million

Cynosure, Inc. (NASDAQ: CYNO) today reported revenues for the three months ended September 30, 2016 of $106.4 million, an increase of 36 percent from ...

Oct 11, 2016, 08:30 ET Cynosure To Host Third-Quarter 2016 Financial Results Conference Call On October 25

Cynosure, Inc. (Nasdaq: CYNO), which designs, manufactures and markets medical devices for aesthetic procedures and precision surgical applications...

Sep 30, 2016, 08:45 ET Cynosure Recognized as One of FORTUNE's 100 Fastest-Growing Companies

Cynosure, Inc. (NASDAQ: CYNO) which designs, manufactures and markets medical devices for aesthetic procedures and precision surgical applications...

Sep 13, 2016, 08:30 ET Cynosure to Name Stephen J. Webber as New Chief Financial Officer

Cynosure, Inc. (NASDAQ: CYNO) today announced that Stephen J. Webber will join the Company on October 10, 2016 as Executive Vice President. Mr....

Jul 26, 2016, 08:00 ET Cynosure Reports Net Income of $6.3 Million on Record Sales of $110.3 Million for the Second Quarter of 2016

Cynosure, Inc. (NASDAQ: CYNO) today reported second-quarter 2016 net income of $6.3 million, or $0.27 per diluted share, an increase of 18.3 percent...

Jul 26, 2016, 07:55 ET Cynosure Receives Approval to Market SculpSure® in South Korea

Cynosure, Inc. (NASDAQ: CYNO) today announced that it has received approval from the Korean Ministry of Food and Drug Safety (MFDS) to market...

Jul 14, 2016, 08:30 ET Cynosure To Host Second-Quarter 2016 Financial Results Conference Call On July 26

Cynosure, Inc. (NASDAQ: CYNO), which designs, manufactures and markets medical devices for aesthetic procedures and precision surgical applications...

Jul 13, 2016, 08:30 ET Cynosure Receives Health Canada Authorization to Market SculpSure®

Cynosure, Inc. (NASDAQ: CYNO) today announced that it has received a medical device license issued by Health Canada to market SculpSure® for...

Jun 16, 2016, 08:30 ET Cynosure to Ring NASDAQ Stock Market Closing Bell to Celebrate 25 Year Anniversary

Cynosure, Inc. (NASDAQ: CYNO) today announced that President and CEO Michael Davin, along with other members of the Company's management team, will...

May 25, 2016, 08:30 ET Cynosure Announces Planned Retirement of Timothy W. Baker as President, Chief Financial Officer and Chief Operating Officer

Cynosure, Inc. (NASDAQ: CYNO) today announced that Timothy W. Baker has notified the Company that he plans to retire to pursue philanthropic...

May 24, 2016, 08:30 ET Cynosure Receives FDA Clearance to Market New PicoSure® Energy Delivery System for Tattoos and Pigmented Lesions

Broadening its product platform for tattoo removal and skin revitalization, Cynosure, Inc. (NASDAQ: CYNO) today announced that it has received U.S....